This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buissa-Filho, R.
Right arrow Articles by Taborda, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buissa-Filho, R.
Right arrow Articles by Taborda, C. P.

 Previous Article  |  Next Article 

Infection and Immunity, July 2008, p. 3321-3328, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00349-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB/c Mice Challenged Intratracheally with the Fungus{triangledown}

R. Buissa-Filho,1 R. Puccia,2 A. F. Marques,1 F. A. Pinto,1 J. E. Muñoz,1 J. D. Nosanchuk,3 L. R. Travassos,2 and C. P. Taborda1*

Institute of Biomedical Sciences, Department of Microbiology, University of São Paulo, São Paulo, SP, Brazil,1 Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo, São Paulo, SP, Brazil,2 Departments of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York3

Received 17 March 2008/ Returned for modification 8 April 2008/ Accepted 24 April 2008

The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. In the present study, we analyzed the effects of monoclonal antibodies on the major diagnostic antigen (gp43) using in vitro and in vivo P. brasiliensis infection models. The passive administration of some monoclonal antibodies (MAbs) before and after intratracheal or intravenous infections led to a reduced fungal burden and decreased pulmonary inflammation. The protection mediated by MAb 3E, the most efficient MAb in the reduction of fungal burden, was associated with the enhanced phagocytosis of P. brasiliensis yeast cells by J774.16, MH-S, or primary macrophages. The ingestion of opsonized yeast cells led to an increase in NO production by macrophages. Passive immunization with MAb 3E induced enhanced levels of gamma interferon in the lungs of infected mice. The reactivity of MAb 3E against a panel of gp43-derived peptides suggested that the sequence NHVRIPIGWAV contains the binding epitope. The present work shows that some but not all MAbs against gp43 can reduce the fungal burden and identifies a new peptide candidate for vaccine development.


* Corresponding author. Mailing address: Institute of Biomedical Sciences, Department of Microbiology, University of São Paulo, Ave. Prof. Lineu Prestes, 1374, 2° andar, São Paulo, SP 05508-900, Brazil. Phone: 55-11-3091-7345. Fax: 55-11-3091-7354. E-mail: taborda{at}usp.br

{triangledown} Published ahead of print on 5 May 2008.

Editor: W. A. Petri, Jr.


Infection and Immunity, July 2008, p. 3321-3328, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00349-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Tian, H., Weber, S., Thorkildson, P., Kozel, T. R., Pirofski, L.-a. (2009). Efficacy of Opsonic and Nonopsonic Serotype 3 Pneumococcal Capsular Polysaccharide-Specific Monoclonal Antibodies against Intranasal Challenge with Streptococcus pneumoniae in Mice. Infect. Immun. 77: 1502-1513 [Abstract] [Full Text]  
  • Braga, C. J. M., Rittner, G. M. G., Munoz Henao, J. E., Teixeira, A. F., Massis, L. M., Sbrogio-Almeida, M. E., Taborda, C. P., Travassos, L. R., Ferreira, L. C. S. (2009). Paracoccidioides brasiliensis Vaccine Formulations Based on the gp43-Derived P10 Sequence and the Salmonella enterica FliC Flagellin. Infect. Immun. 77: 1700-1707 [Abstract] [Full Text]